Skip to Main Content

Author Details

Sarah Fidler
1988
264
40
PMIDPaper TitleJournal TitlePublished Year
37542278Managing household income and antiretroviral therapy adherence among people living with HIV in a low-income setting: a qualitative data from the HPTN 071 (PopART) trial in South Africa.2023
36196614Booster Vaccination Against SARS-CoV-2 Induces Potent Immune Responses in People With Human Immunodeficiency Virus.Clinical Infectious Diseases2023
37792229Cultural Adaption, Translation, Preliminary Reliability and Validity of Key Psychological and Behavioural Measures for 18 to 25 Year-Olds Living with HIV in Uganda: A Multi-Stage Approach.2023
37152187Characterization of Rare Spontaneous Human Immunodeficiency Virus Viral Controllers Attending a National United Kingdom Clinical Service Using a Combination of Serology and Molecular Diagnostic Assays.2023
37340497Does distribution of menstrual products through community-based, peer-led sexual and reproductive health services increase use of appropriate menstrual products? Findings from the Yathu Yathu trial.2023
37279784Sexual and reproductive health needs of young women living with perinatally acquired HIV.2023
37083700The impact of community-based, peer-led sexual and reproductive health services on knowledge of HIV status among adolescents and young people aged 15 to 24 in Lusaka, Zambia: The Yathu Yathu cluster-randomised trial.2023
36895110Evaluating virological outcomes in people with HIV on stable antiretroviral therapy with reduced frequency of HIV viral load monitoring during the COVID-19 pandemic.2023
37450474The impact of a combined TB/HIV intervention on the incidence of TB infection among adolescents and young adults in the HPTN 071 (PopART) trial communities in Zambia and South Africa.2023
37001128Brief Report: How Do We Reach Men? Offering HIV Testing in Evenings and Weekends in the HPTN 071 (PopART) Community-Based Trial in South Africa.2023
37061309Use of point-of-care C-reactive protein testing for screening of tuberculosis in the community in high-burden settings: a prospective, cross-sectional study in Zambia and South Africa.2023
36684396COVAC1 phase 2a expanded safety and immunogenicity study of a self-amplifying RNA vaccine against SARS-CoV-2.2023
36727597Uptake of medical male circumcision with household-based testing, and the association of traditional male circumcision and HIV infection.2023
34873077Immunotherapeutic approaches to HIV cure and remission.Current Opinion in Infectious Diseases2022
36376307Third primary SARS-CoV-2 mRNA vaccines enhance antibody responses in most patients with haematological malignancies.Nature Communications2022
36110857Impact of antiretroviral therapy in primary HIV infection on natural killer cell function and the association with viral rebound and HIV DNA following treatment interruption.Frontiers in Immunology2022
35775502HIV drug resistance in a community-randomized trial of universal testing and treatment: HPTN 071 (PopART).Journal of the International AIDS Society2022
36309514Administration of broadly neutralizing anti-HIV-1 antibodies at ART initiation maintains long-term CD8 T cell immunity.Nature Communications2022
35710250Optimising Xpert-Ultra and culture testing to reliably measure tuberculosis prevalence in the community: findings from surveys in Zambia and South Africa.BMJ Open2022
35818869The association between HIV stigma and HIV incidence in the context of universal testing and treatment: analysis of data from the HPTN 071 (PopART) trial in Zambia and South Africa.Journal of the International AIDS Society2022
35439790An exploration of how broadly neutralizing antibodies might induce HIV remission: the 'vaccinal' effect.2022
36007134Impact of SARS-CoV-2 pandemic on viral suppression for young adults living with perinatally acquired HIV infection.AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV2022
35421966Adapting community-based sexual and reproductive health services for adolescents and young people aged 15-24 years in response to COVID-19 in Lusaka, Zambia: the implications on the uptake of HIV testing services.BMC Health Services Research2022
36332652Viral suppression and self-reported ART adherence after 3 years of universal testing and treatment in the HPTN 071 (PopART) community-randomised trial in Zambia and South Africa: a cross-sectional analysis.Lancet HIV,The2022
36332653Impact of universal testing and treatment on sexual risk behaviour and herpes simplex virus type 2: a prespecified secondary outcomes analysis of the HPTN 071 (PopART) community-randomised trial.Lancet HIV2022
36332648Lessons from the HPTN 071 (PopART) trial.Lancet HIV,The2022
36194628Enhanced immune responses following heterologous vaccination with self-amplifying RNA and mRNA COVID-19 vaccines.PLoS Pathogens2022
36191598Disseminating complex primary outcome results from a community-randomised trial to Zambian communities: lessons learned using a community dialogue approach in the HPTN 071 (PopART) trial.Lancet HIV,The2022
36447611Antiretroviral Drug Detection in a Community-Randomized Trial of Universal HIV Testing and Treatment: HPTN 071 (PopART).Open Forum Infectious Diseases2022
36253609Early intervention with 3BNC117 and romidepsin at antiretroviral treatment initiation in people with HIV-1: a phase 1b/2a, randomized trial.Nature Medicine2022
36514036Achieving the UNAIDS 90-90-90 targets: a comparative analysis of four large community randomised trials delivering universal testing and treatment to reduce HIV transmission in sub-Saharan Africa.2022
36504313BHIVA guidelines on antiretroviral treatment for adults living with HIV-1 2022.2022
36561760Women for science and science for women: Gaps, challenges and opportunities towards optimizing pre-exposure prophylaxis for HIV-1 prevention.2022
36741409Systematic comparison of HIV-1 Envelope-specific IgG responses induced by different vaccination regimens: Can we steer IgG recognition towards regions of viral vulnerability?2022
36454874Depressive symptoms and HIV risk behaviours among adolescents enrolled in the HPTN071 (PopART) trial in Zambia and South Africa.PLoS ONE2022
34304330Acceptability and Preferences of Two Different Community Models of ART Delivery in a High Prevalence Urban Setting in Zambia: Cluster-Randomized Trial, Nested in the HPTN 071 (PopART) Study.AIDS and Behavior2022
34302282Uptake of HIV Testing Services Through Novel Community-Based Sexual and Reproductive Health Services: An Analysis of the Pilot Implementation Phase of the Yathu Yathu Intervention for Adolescents and Young People Aged 15-24 in Lusaka, Zambia.AIDS and Behavior2022
33183361Psychotic disorders in young adults with perinatally acquired HIV: a UK case series.Psychological Medicine2022
35194929Response to 'The use of tenofovir in patients with COVID-19'.HIV Medicine2022
35192543Durability of ChAdOx1 nCoV-19 vaccination in people living with HIV.JCI insight2022
34555242Clinical outcomes of patients with and without HIV hospitalized with COVID-19 in England during the early stages of the pandemic: a matched retrospective multi-centre analysis (RECEDE-C19 study).HIV Medicine2022
35165795Intimate Partner Violence (IPV) and Associated Factors in HPTN 071 (PopART) Study Communities in Zambia and South Africa-A Comparison by HIV Status.AIDS and Behavior2022
35013427Expression of type I interferon-associated genes at antiretroviral therapy interruption predicts HIV virological rebound.Scientific Reports2022
35001530Closing the gap: did delivery approaches complementary to home-based testing reach men with HIV testing services during and after the HPTN 071 (PopART) trial in Zambia?Journal of the International AIDS Society2022
35138683Mitigation strategies to safely conduct HIV treatment research in the context of COVID-19.J Int AIDS Soc2022
34874540Correlation between cerebrospinal fluid and plasma neurofilament light protein in treated HIV infection: results from the COBRA study.Journal of NeuroVirology2022
34592959Insaka: mobile phone support groups for adolescent pregnant women living with HIV.BMC Pregnancy and Childbirth2021
33645374The act of telling: South African women's narratives of HIV status disclosure to intimate partners in the HPTN 071 (PopART) HIV prevention trial.Women's Health2021
34127581Broadly neutralizing antibody responses in the longitudinal primary HIV-1 infection Short Pulse Anti-Retroviral Therapy at Seroconversion cohort.AIDS2021
33964099Tolerability of four-drug antiretroviral combination therapy in primary HIV-1 infection.HIV Medicine2021
  • 1 - 50 of 263

Recommended Authors

Collaborators

Co-authored papers 17
Co-authored papers 12
Co-authored papers 11
Co-authored papers 5
The Hospital for Sick Children
Co-authored papers 5
University of California san francisco
Co-authored papers 4
Department of Medicine Johns Hopkins Medicine. Baltimore MD 21205USA.
Co-authored papers 4
Frederick National Laboratory for Cancer Research, National Cancer Institute
Co-authored papers 3
Co-authored papers 3
Co-authored papers 3
The University of Melbourne at the Peter Doherty Institute for Infection and Immunity
Co-authored papers 3
Sydney Institute for Infectious Diseases, The University of Sydney
Co-authored papers 2
Co-authored papers 2
Co-authored papers 2
Co-authored papers 2
Co-authored papers 2
Co-authored papers 2
Co-authored papers 2
Brigham and Women's Hospital, Harvard Medical School
Co-authored papers 2
Center for AIDS Research, University of California San Diego
Co-authored papers 2
Ragon Institute of Mass General
Co-authored papers 2
Co-authored papers 2
Co-authored papers 2
Co-authored papers 2
University of Alabama at Birmingham
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1